155 results
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
17 Jan 12
Current report (foreign)
12:00am
to ($743,000), compared to ($156,000) obtained during the corresponding period ended November 30, 2010, due to subsidiaries significant R&D expenses.
Net … period ended November 30, 2010, due to subsidiaries significant R&D expenses.
"We delivered strong third quarter revenue driven by outstanding
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
13 Nov 18
Current report (foreign)
4:03pm
Total revenues
Gross margin
R&D expenses, net of tax credits and grants
SG&A expenses
Segment income (loss) from operating activities before … -month period ended September 30, 2017
Inter-segment
Nutraceutical
Cardiovascular
Corporate
eliminations
Total revenues
Gross margin
R&D expenses, net
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
14 Aug 18
Management Discussion and Analysis of the Financial Situation and Operating Results for the Three-month Periods Ended June 30, 2018 and 2017
5:15pm
, 2018
Nutraceutical
Cannabis
Corporate
Total revenues
Gross margin
R&D expenses, net of tax credits and grants
SG&A expenses
Segment income (loss) from … margin
R&D expenses, net of tax credits and grants
SG&A expenses
Segment income (loss) from operating activities before
corporate expenses
Unallocated
6-K
EX-99.7
NEPTF
Neptune Wellness Solutions Inc
25 May 12
Current report (foreign)
12:00am
from North America, Europe and Asia.
On the R&D front, the Company presented on March 24th 2011 at the 2011 Scientific Sessions of the American … preclinical Good Laboratory Practices (GLP) program (IND-enabling program). Within the preclinical R&D program, Acasti reported preclinical results showing
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
5 Jun 18
Current report (foreign)
5:07pm
Gross margin
R&D expenses
R&D tax credits and grants
SG&A
Other income – net gain on sale of assets
Loss from operating activities
Net finance cost …
Inter-segment
Total
eliminations
Total revenues
Gross margin
R&D expenses
R&D tax credits and grants
SG&A
Other income – royalty settlements
Income
6-K
EX-99.1
p1qxc 34yrje
5 Jun 18
Neptune Announces Fourth Quarter and Year-end Results
5:09pm
6-K
EX-99.1
7nkhzui1y0e15o9 z8is
7 Jun 17
Current report (foreign)
12:00am
6-K
EX-99.1
vx3wgwf2ar12qur qums
7 Jun 17
Neptune Announces 4-Month Period and 13-Month Period Results
12:00am
40-F
EX-99.3
ozdziqis acv8wxjjy9
28 Jun 18
Annual report (Canada)
4:32pm
6-K
EX-99.1
ll9li2 q7hra
13 Feb 19
Current report (foreign)
4:00pm
6-K
EX-99.5
jc76g 9yonj98803ppwn
14 Oct 11
Current report (foreign)
12:00am
40-F
EX-99.3
sotq1q
12 Jun 19
Annual report (Canada)
4:57pm
40-F
EX-99.3
skonee
10 Jun 20
Annual report (Canada)
4:36pm
40FR12B/A
EX-99.0.1
z1d 6ieskx8
13 Jul 07
Initial registration of securities (Canada) (amended)
12:00am
6-K
EX-99.1
owv p8cl4
16 Jul 12
Management Analysis of the Financial Situation
12:00am
40-F
EX-99.3
yiwudfhf4
29 May 12
Annual report (Canada)
12:00am
6-K
EX-99.1
85bok7l9
2 Apr 08
The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies’ Ingredients for New Essentially Brand
12:00am
6-K
EX-99.1
bksaik259 4cn
12 Nov 19
Neptune Reports Fiscal 2020 Second Quarter Results
7:31am
6-K
EX-99.1
wkst6otlmpoxpr6
12 Nov 19
Current report (foreign)
7:00am
6-K
EX-99.1
w0xt2eez6f3
13 Nov 18
Neptune Announces Second Quarter Results
4:21pm